V. Scattoni

U. Capitanio, F. Montorsi, V. Scattoni, 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.

U. Capitanio, F. Montorsi, A. Salonia, 2013, The Journal of urology.

A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy.

F. Fazio, F. Montorsi, P. Rigatti, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.

F. Montorsi, A. Salonia, A. Cestari, 2008, European urology.

11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS

F. Montorsi, P. Rigatti, M. Picchio, 2008 .

Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2007, Urology.

Evaluating Serum Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein 3 as Markers in Prostate Cancer Diagnosis

R. Dittadi, L. Peloso, M. Gion, 2016, The International journal of biological markers.

Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.

V. Ficarra, M. Gion, V. Scattoni, 2007, Anticancer research.

Diagnosis of local recurrence after radical prostatectomy

F. Fazio, F. Montorsi, A. Salonia, 2004, BJU international.

Potency after Radical Prostatectomy: From New Techniques to Better Results

F. Montorsi, A. Salonia, F. Fabbri, 2006 .

Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial.

F. Montorsi, A. Salonia, P. Rigatti, 2008, European urology.

Pathophysiology of erectile dysfunction.

F. Montorsi, A. Salonia, P. Rigatti, 2003, International journal of andrology.

Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial.

U. Capitanio, F. Montorsi, A. Salonia, 2022, European urology focus.

Reply from Authors re: Andrew J. Vickers, Hans Lilja. PSA Is Dead, Long Live PSA. Eur Urol 2012;61:467–8

F. Montorsi, A. Cestari, P. Rigatti, 2012 .

Thermo–Chemotherapy and Electromotive Drug Administration of Mitomycin C in Superficial Bladder Cancer Eradication

F. Montorsi, A. Salonia, P. Rigatti, 2000, European Urology.

US Contrast Media in Prostatic Disease

V. Scattoni, C. Maccagnano, 2017 .

Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.

F. Montorsi, A. Salonia, P. Rigatti, 2000, Journal of andrology.

374 EXTERNAL VALIDATION OF THE EAU GUIDELINES FOR PELVIC LYMPH NODE DISSECTION AMONG PATIENTS TREATED WTH ROBOTIC ASSISTED RADICAL PROSTATECTOMY

F. Montorsi, A. Cestari, N. Fossati, 2013 .

Re: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)

V. Scattoni, 2008 .

Systematic review of complications of prostate biopsy.

Yair Lotan, Mark Emberton, Hashim U Ahmed, 2013, European urology.

Perianal and intrarectal anaesthesia for transrectal biopsy of the prostate: a prospective randomized study comparing lidocaine‐prilocaine cream and placebo

F. Montorsi, P. Rigatti, M. Roscigno, 2005, BJU international.

Dorsal onlay graft urethroplasty using penile skin or buccal mucosa for repair of bulbar urethral stricture: results of a prospective single center study.

F. Montorsi, A. Salonia, P. Rigatti, 2005, European urology.

Pathological Findings in TRUS Prostatic Biopsy—Diagnostic, Prognostic and Therapeutic Importance

D. Bostwick, R. Montironi, V. Scattoni, 2002 .

Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").

Antonio Lopez-Beltran, Rodolfo Montironi, Francesco Montorsi, 2006, European urology.

Predictive models before and after radical prostatectomy

U. Capitanio, F. Montorsi, A. Briganti, 2010, The Prostate.

Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2007, European urology.

Development and external validation of an extended repeat biopsy nomogram.

A. Haese*, F. Montorsi, A. Salonia, 2007, The Journal of urology.

Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.

F. Montorsi, J. Epstein, S. Freedland, 2010, European urology.

Ureteral Endometriosis: Proposal for a Diagnostic and Therapeutic Algorithm with a Review of the Literature

F. Montorsi, M. Ghezzi, P. Rigatti, 2013, Urologia Internationalis.

Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable?

F. Montorsi, A. Salonia, P. Rigatti, 2003, The Journal of urology.

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

C. Roehrborn, A. Haese*, F. Montorsi, 2006, BJU international.

PD38-12 [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAÏVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY

F. Montorsi, M. Picchio, L. Gianolli, 2015 .

Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art

U. Capitanio, F. Montorsi, P. Rigatti, 2012, Urologia Internationalis.

Anaesthesia in Transrectal Prostate Biopsy: Which Is the Most Effective Technique?

F. Montorsi, P. Rigatti, M. Roscigno, 2011, Urologia Internationalis.

Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy

V. Bettinardi, F. Fazio, P. Rigatti, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.

F. Fazio, F. Montorsi, P. Rigatti, 2008, European urology.

[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.

F. Montorsi, A. Salonia, P. Rigatti, 2010, The Journal of urology.

PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

F. Montorsi, M. Picchio, L. Gianolli, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

F. Fazio, P. Rigatti, M. Picchio, 2007, European urology.

Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2006, European urology.

The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting.

U. Capitanio, F. Montorsi, A. Salonia, 2014, Urology.

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.

U. Capitanio, F. Montorsi, V. Bini, 2013, The Journal of urology.

Neoadjuvant CMV Chemotherapy plus Radical Cystectomy in Locally Advanced Bladder Cancer: The Impact of Pathologic Response on Long-Term Results

P. Rigatti, A. Bolognesi, T. Torelli, 1996, Tumori.

Biopsy of the Vesico-Urethral Anastomosis after Radical Prostatectomy: When and How

P. Rigatti, L. D. Pozzo, M. Roscigno, 2002 .

Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre

F. Montorsi, A. Salonia, P. Rigatti, 2013, BJU international.

Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care

Rodolfo Montironi, Osamu Ukimura, Mark Emberton, 2013 .

The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.

U. Capitanio, F. Montorsi, P. Rigatti, 2011, European urology.

Comparison of a 3‐day with a 1‐day regimen of an extended‐release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate

F. Montorsi, A. Schaeffer, V. Scattoni, 2007, BJU international.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound‐guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy

U. Capitanio, F. Montorsi, A. Salonia, 2012, BJU international.

The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy

U. Capitanio, F. Montorsi, A. Salonia, 2011, BJU international.

Development and external validation of an extended 10-core biopsy nomogram.

A. Haese*, F. Montorsi, P. Rigatti, 2007, European urology.

Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.

U. Capitanio, F. Montorsi, P. Rigatti, 2008, European urology.

A Critical assessment of extracorporeal shock-wave therapy for Peyronie’s disease

F. Montorsi, A. Salonia, A. Briganti, 2004 .

Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.

F. Montorsi, N. Fossati, G. Gandaglia, 2018, European urology oncology.

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.

F. Montorsi, P. Rigatti, V. Bini, 2011, European urology.

131 PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY

A. Cestari, M. Zanoni, V. Bini, 2011 .

Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy.

F. Montorsi, R. Montironi, M. Roscigno, 2010, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy.

Francesco Montorsi, Patrizio Rigatti, F. Montorsi, 2004, Urology.

260 Isolated mono- and pluri-focal high grade prostatic intraepithelial neoplasia (HGPIN) on initial extended prostate needle biopsies: factors predicting cancer detection on extended re-biopsy

F. Montorsi, P. Rigatti, M. Roscigno, 2004 .

Diagnosis of isolated high‐grade prostatic intra‐epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re‐biopsy

F. Montorsi, R. Montironi, M. Roscigno, 2012, BJU international.

Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate?

F. Montorsi, A. Cestari, P. Rigatti, 2011, Urology.

Failures and complications of transurethral ureteroscopy in 297 cases: conventional rigid instruments vs. small caliber semirigid ureteroscopes.

P. Rigatti, V. Scattoni, F. Francesca, 1995, European urology.

Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature.

Rodolfo Montironi, Francesco Montorsi, Patrizio Rigatti, 2007, European urology.

Transrectal Saturation Biopsy

F. Montorsi, V. Scattoni, C. Maccagnano, 2013 .

[Percutaneous echo-guided drainage and sclerotherapy of symptomatic renal cysts: critical comparison with laparoscopic treatment].

P. Rigatti, V. Scattoni, G. Guazzoni, 1996, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Practical recommendations for performing ultrasound scanning in the urological and andrological fields.

S. Palazzo, A. Granata, V. Scattoni, 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Diagnosis and Treatment of Bladder Endometriosis: State of the Art

F. Montorsi, M. Ghezzi, P. Rigatti, 2012, Urologia Internationalis.

Benign prostatic hyperplasia with PSA > 10.0 ng/ml: Correlations between PSA density and pathological findings of the surgical specimen after open prostatectomy

V. Scattoni, E. Tavani, G. Marcelli, 1995 .

Ten-year Follow-up Results After Holmium Laser Enucleation of the Prostate.

F. Montorsi, A. Salonia, P. Capogrosso, 2020, European urology focus.

Benign Prostatic Hypertrophy

V. Scattoni, C. Maccagnano, 2017 .

Is extended and saturation biopsy necessary?

F. Montorsi, P. Rigatti, M. Roscigno, 2010, International journal of urology : official journal of the Japanese Urological Association.

Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up.

Andrea Salonia, Andrea Cestari, Francesco Montorsi, 2006, European urology.

Clinical comparison of holmium laser enucleation of the prostate (HoLEP) and bipolar transurethral enucleation of the prostate (BTUEP) in patients under either anticoagulation or antiplatelet therapy

F. Montorsi, A. Salonia, P. Capogrosso, 2019, European Urology Supplements.

Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve.

F. Montorsi, A. Salonia, A. Briganti, 2023, European urology focus.

Local anaesthesia for prostate biopsy by perianal lidocaine injection: A double-blind, placebo controlled study

F. Montorsi, P. Rigatti, V. Scattoni, 2003 .

[11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

V. Bettinardi, F. Fazio, M. Picchio, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Spatial distribution of positive cores improves the selection of patients with low‐risk prostate cancer as candidates for active surveillance

U. Capitanio, F. Montorsi, P. Rigatti, 2013, BJU international.

Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study.

F. Montorsi, A. Salonia, P. Rigatti, 2000, Urology.

Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study.

A. Haese*, M. Graefen, A. De la taille, 2013, European urology.

Percent of Free Serum Prostate-Specific Antigen and Histological Findings in Patients Undergoing Open Prostatectomy for Benign Prostatic Hyperplasia

F. Montorsi, P. Rigatti, V. Scattoni, 1999, European Urology.

Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer.

P. Rigatti, A. Del Maschio, V. Scattoni, 1996, The Journal of urology.

Medical therapy of prostate cancer. A review.

M. Sangalli, P. Rigatti, M. Roscigno, 2005, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

MC (cisplatin and methotrexate) adjuvant chemotherapy after cystectomy versus MC neoadjuvant chemotherapy following cystectomy in locally advanced bladder cancer: Results after 10 years of experience

G. Martignoni, V. Scattoni, G. Pavia, 1995 .

Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.

F. Montorsi, A. Cestari, P. Rigatti, 2012, European urology.

Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.

F. Montorsi, A. Cestari, P. Rigatti, 2012, The Journal of urology.

Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.

F. Montorsi, A. Zlotta, L. Boccon‐Gibod, 2004, European urology.

Approaches for Initial Prostate Biopsy and Antibiotic Prophylaxis.

V. Scattoni, G. Giannarini, G. Ploussard, 2015, European urology focus.

Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer.

P. Rigatti, T. Torelli, V. Scattoni, 1995, European urology.

Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights.

R. Montironi, M. Fiorentino, C. Gaudiano, 2017, Anticancer research.

Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU)

S. Palazzo, M. Battaglia, V. Scattoni, 2011, World Journal of Urology.

Random biopsy: when, how many and where to take the cores?

U. Capitanio, F. Montorsi, A. Briganti, 2014, World Journal of Urology.

Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?

F. Montorsi, F. Sanguedolce, G. Carrieri, 2014, World Journal of Urology.

Re: saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.

V. Scattoni, 2008, European urology.

Editorial comment on: comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis.

V. Scattoni, 2008, European urology.

Interventional Ultrasound: Prostatic Biopsy with Special Techniques (Saturation, Template)

V. Scattoni, C. Maccagnano, 2017 .

Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.

U. Capitanio, F. Montorsi, P. Rigatti, 2010, European urology.

Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder

F. Fabbri, P. Rigatti, V. Scattoni, 2007, Therapeutics and clinical risk management.

Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.

F. Montorsi, P. Rigatti, M. Roscigno, 2003, European urology.

Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower

A. Haese*, F. Montorsi, M. Graefen, 2008, Cancer.

Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies.

Andrea Salonia, Francesco Montorsi, Patrizio Rigatti, 2005, Urology.

Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.

F. Montorsi, P. Rigatti, C. Fiorino, 2009, International journal of radiation oncology, biology, physics.

Prostatic Transrectal Ultrasound (TRUS) Guided Biopsy Schemes and TRUS Prostatic Lesion-Guided Biopsies

Francesco Montorsi, Patrizio Rigatti, F. Montorsi, 2002 .

Topical prilocaine–lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: Results from a prospective randomized trial

F. Montorsi, A. Salonia, P. Rigatti, 2008 .

[Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure].

F. Montorsi, P. Rigatti, M. Roscigno, 2002, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.

F. Montorsi, P. Rigatti, A. Briganti, 2005, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.

A. Cestari, V. Bini, A. Larcher, 2012, The Journal of urology.

Reply from Authors re: Stacy Loeb. Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker? Eur Urol 2013;63:995–6

A. Haese*, M. Graefen, V. Bini, 2013 .

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

A. Kibel, M. Roobol, M. Emberton, 2013, European urology.

Re: Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?

V. Scattoni, L. Villa, 2010 .

Diagnosis of prostate cancer. State of the art.

R Bertini, F. Montorsi, P. Rigatti, 2004, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.

U. Capitanio, F. Montorsi, P. Rigatti, 2010, European urology.

Systematic prostate biopsies are more and more often becoming saturation biopsies.

V. Scattoni, Vincenzo Scattoni, 2006, European urology.

Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.

U. Capitanio, F. Montorsi, A. Salonia, 2008, European urology.

Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center.

F. Montorsi, A. Salonia, P. Capogrosso, 2021, Minerva urology and nephrology.

Is extended and saturation biopsy necessary?

F. Montorsi, P. Rigatti, M. Roscigno, 2010, International journal of urology : official journal of the Japanese Urological Association.

Repeated biopsy in the detection of prostate cancer: when and how many cores.

U. Capitanio, F. Montorsi, V. Scattoni, 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.